Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 公共衛生學院
  3. 流行病學與預防醫學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58186
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor方啟泰(Chi-Tai Fang)
dc.contributor.authorYing-Ying Linen
dc.contributor.author林盈瑩zh_TW
dc.date.accessioned2021-06-16T08:07:46Z-
dc.date.available2015-10-20
dc.date.copyright2014-10-20
dc.date.issued2014
dc.date.submitted2014-06-07
dc.identifier.citation1. Sanfelice F (1894) Contributo alla morfologia e biologia dei blastomiceti che si sviluppano nei succhi di alcuni frutti. Ann Igien 463–495.
2. Buschke A (1895) U‥ ber eine durch Coccidien Hervergerufene Krankheit des menschen. Dtsch Med Wochenschr 21: 14.
3. Busse O (1894) U‥ ber parasita‥re zelleinschlu‥sse und ihre zu‥chtung. Zentralbl Bakteriol 16: 175-180.
4. Hansemann DV (1905) U‥ ber eine bisher nicht beobachtete Gehirner Krankung durch Hefen. Verh. Dtsch. Ges. Pathol. Verh Dtsch Ges Pathol 9:21–24.
5. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, et al. (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23: 525-530.
6. WHO (2011) Diagnosis, Pr evention and Management of Cr yptococcal Disease in HIV -infected Adults, Adolescents and Ch ildren. Rapid Advice.
7. Graybill JR, Drutz DJ (1978) Host defense in cryptococcosis. II. Cryptococcosis in the nude mouse. Cell Immunol 40: 263-274.
8. Cauley LK, Murphy JW (1979) Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection. Infect Immun 23: 644-651.
9. Nishimura K, Miyaji M (1979) Histopathological studies on experimental cryptococcosis in nude mice. Mycopathologia 68: 145-153.
10. Salkowski CA, Balish E (1990) Pathogenesis of Cryptococcus neoformans in congenitally immunodeficient beige athymic mice. Infect Immun 58: 3300-3306.
11. Salkowski CA, Balish E (1991) Inflammatory responses to cryptococcosis in congenitally athymic mice. J Leukoc Biol 49: 533-541.
12. Salkowski CA, Balish E (1991) Cutaneous cryptococcosis in athymic and beige-athymic mice. Infect Immun 59: 1785-1789.
13. Kovacs JA, Kovacs AA, Polis M, Wright WC, Gill VJ, et al. (1985) Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 103: 533-538.
14. Eng RH, Bishburg E, Smith SM, Kapila R (1986) Cryptococcal infections in patients with acquired immune deficiency syndrome. Am J Med 81: 19-23.
15. Gal AA, Koss MN, Hawkins J, Evans S, Einstein H (1986) The pathology of pulmonary cryptococcal infections in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 110: 502-507.
16. Shimizu RY, Howard DH, Clancy MN (1986) The variety of Cryptococcus neoformans in patients with AIDS. J Infect Dis 154: 1042.
14
17. Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ (1986) Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med 104: 234-240.
18. Chuck SL, Sande MA (1989) Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 321: 794-799.
19. Zoller WG, Kellner H, Goebel FD, Schmiedtke K, Holecek B, et al. (1989) [Cryptococcus neoformans meningoencephalitis and multiple infections in AIDS]. Klin Wochenschr 67: 598-604.
20. Jean SS, Fang CT, Shau WY, Chen YC, Chang SC, et al. (2002) Cryptococcaemia: clinical features and prognostic factors. QJM 95: 511-518.
21. Tseng HK, Liu CP, Ho MW, Lu PL, Lo HJ, et al. (2013) Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010. PLoS One 8: e61921.
22. Lee TK CW, Hsu CJ, Yang SP (1959) Cryptococcosis: A review with two case reports. J Formosan Med Assoc 58:567-578.
23. Chen YC, Chang SC, Shih CC, Hung CC, Luhbd KT, et al. (2000) Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan. Diagn Microbiol Infect Dis 36: 175-183.
24. Cholongitas E, Papatheodoridis GV, Vangeli M, Terreni N, Patch D, et al. (2005) Systematic review: the model for end-stage liver disease – should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Alimentary Pharmacology & Therapeutics 22: 1079-1089.
25. Jean SS, Wang JL, Wang JT, Fang CT, Chen YC, et al. (2005) Cryptococcus neoformans peritonitis in two patients with liver cirrhosis. J Formos Med Assoc 104: 39-42.
26. Pappas PG (2013) Cryptococcal infections in non-hiv-infected patients. Trans Am Clin Climatol Assoc 124: 61-79.
27. Shih CC, Chen YC, Chang SC, Luh KT, Hsieh WC (2000) Cryptococcal meningitis in non-HIV-infected patients. QJM 93: 245-251.
28. Singh N, Alexander BD, Lortholary O, Dromer F, Gupta KL, et al. (2007) Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis 195: 756-764.
29. French N, Gray K, Watera C, Nakiyingi J, Lugada E, et al. (2002) Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS 16: 1031-1038.
30. Akalin HE, Laleli Y, Telatar H (1985) Serum bactericidal and opsonic activities in patients with non-alcoholic cirrhosis. Q J Med 56: 431-437.
31. DeMeo AN, Andersen BR, English DK, Peterson J (1972) Defective Chemotaxis Associated with a Serum Inhibitor in Cirrhotic Patients. New England Journal of Medicine 286: 735-740.
32. Holdstock G, Chastenay BF, Krawitt EL (1982) Studies on lymphocyte hyporesponsiveness in cirrhosis: the role of increased monocyte suppressor cell activity. Gastroenterology 82: 206-212.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58186-
dc.description.abstractBackground
Cryptococcus neoformans is a widespread environmental fungus that is frequently found in the excrement of pigeons. C. neoformans can invade the central nervous system and cause life-threatening cryptococcal meningitis. Additionally, C. neoformans can invade the bloodstream and cause cryptococcemia, which carries a high risk of mortality. Previously, we conducted the first cohort study on the clinical outcomes of cryptococcemia. Among the 52 cases, the three most common underlying host diseases/conditions were acquired immunodeficiency syndrome (AIDS), immunosuppressive therapy, and decompensated liver cirrhosis. Whether the above-stated factors increase the risk for developing cryptococcosis is unclear. There is still no case-control study that examined the role of these factors in the pathogenesis of invasive cryptococcal diseases.
Aims
To identify the risk factors for invasive cryptococcal diseases, i.e., cryptococcemia and cryptococcal meningitis, we performed a hospital-based, retrospective, density-sampling case-control study.
Methods
This retrospective, density-sampling, matched case-control study was conducted at the National Taiwan University Hospital (NTUH). The study procedure was reviewed and approved by the institutional review board of the NTUH (No. 201101083RC). All of the cryptococcemia patients (blood culture-positive) and cryptococcal meningitis patients (cerebral spinal fluid [CSF] culture-proven) at the NTUH from Jan. 1, 2002 to Dec. 31, 2010 were included as cases. The controls were selected from patients hospitalized at the NTUH without a diagnosis of cryptococcemia or cryptococcal meningitis. The controls and cases were individually matched by admission date, age, and gender at a 4:1 ratio (cryptococcemia) or 2:1 ratio (cryptococcal meningitis). Information on gender, age, and the presence of underlying conditions or environmental exposures was systematically collected using a standardized data format. Exact conditional logistic regression was used to analyze the matched case-control data. A stepwise procedure was used for the multivariate regression analyses.
Results
A total of 101 patients with cryptococcal meningitis (with 266 controls) and 47 patients with cryptococcemia (with 188 controls) were included in this study. Thirty-two patients had both cryptococcal meningitis and cryptococcemia. The multivariate regression analysis showed that AIDS (adjusted odds ratio [OR] = 470.6; 95% confidence interval [CI], 33.4 to >999; p<0.0001), decompensated liver cirrhosis (adjusted OR = 25.5; 95% CI, 3.7 to 174.4; p=0.0009), cell-mediated immunity (CMI)-suppressive therapy (adjusted OR = 36.0; 95% CI, 6.5 to 198.0; p<0.0001), and leukemia/myeloma (adjusted OR = 87.3; 95% CI, 2.9 to >999; p<0.0101) were independent risk factors for cryptococcemia. Additionally, the multivariate regression analysis showed that decompensated liver cirrhosis (adjusted OR = 10.7; 95% CI, 2.3 to 49.4; p=0.0024), AIDS (adjusted OR = 161.9; 95% CI, 21.6 to >999; p<0.0001), and CMI-suppressive therapy (adjusted OR = 9.3; 95% CI, 3.8 to 22.9; p<0.0001) were independent risk factors for cryptococcal meningitis. Cryptococcemia in patients with AIDS was more likely to present with culture-proven meningitis than that in patients with decompensated liver cirrhosis (90% vs. 44.4%, p=0.0079). Patients with decompensated liver cirrhosis were significantly less likely than patients with AIDS to undergo a lumbar puncture for a CSF study (33.3% vs. 0%, p=0.023).
Conclusions
This study confirmed that decompensated liver cirrhosis, AIDS, and CMI-suppressive therapy are independent risk factors for cryptococcemia and cryptococcal meningitis. Invasive cryptococcal diseases should be included in the differential diagnosis in cases in which patients with the above-stated conditions develop fever and/or symptoms of meningitis.
en
dc.description.provenanceMade available in DSpace on 2021-06-16T08:07:46Z (GMT). No. of bitstreams: 1
ntu-103-R01849001-1.pdf: 5389040 bytes, checksum: 7d32222f1d509f542c544e62588d6573 (MD5)
Previous issue date: 2014
en
dc.description.tableofcontents口試委員會審定書 ....................................................................................................... i
誌 謝 ........................................................................................................................... ii
摘 要 ........................................................................................................................ iii
Abstract ...................................................................................................................... vi
Table of Contents ....................................................................................................... ix
List of Tables .............................................................................................................. xi
List of Figures .......................................................................................................... xii
List of Appendices .................................................................................................. xiii
Introduction ................................................................................................................ 1
Methods ....................................................................................................................... 3
Study design ............................................................................................................................. 3
Ethical statement ...................................................................................................................... 3
Setting ....................................................................................................................................... 3
Case selection ........................................................................................................................... 3
Selection of controls ................................................................................................................. 4
Host underlying diseases and environmental exposures .......................................................... 4
Statistical analysis .................................................................................................................... 5
Results ......................................................................................................................... 6
Cryptococcemia cases .............................................................................................................. 6
Cryptococcal meningitis cases ................................................................................................. 6
Risk factors for cryptococcemia ............................................................................................... 7
Risk factors for cryptococcal meningitis .................................................................................. 7
x
Comparison between AIDS-associated cryptococcemia cases and decompensated liver cirrhosis-associated cryptococcemia cases ............................................................................... 8
Comparison of liver cirrhosis severity between cases and controls ......................................... 8
Discussion .................................................................................................................... 9
References ................................................................................................................. 13
Appendix ................................................................................................................... 29
dc.language.isoen
dc.subject隱球菌菌血症zh_TW
dc.subject隱球菌腦膜炎zh_TW
dc.subject病例對照研究zh_TW
dc.subject新型隱球菌zh_TW
dc.subjectCryptococcus neoformansen
dc.subjectCryptococcemiaen
dc.subjectCryptococcal meningitisen
dc.subjectCase-control studyen
dc.subjectExact conditional logistic regressionen
dc.title侵襲性隱球菌感染的危險因子: 病例對照研究zh_TW
dc.titleRisk Factors for Invasive Cryptococcal Diseases: A Case-Control Studyen
dc.typeThesis
dc.date.schoolyear102-2
dc.description.degree碩士
dc.contributor.oralexamcommittee施惟量(Wei-Liang Shih),梁嘉德(Ja-Der Liang),盛望徽
dc.subject.keyword新型隱球菌,隱球菌菌血症,隱球菌腦膜炎,病例對照研究,zh_TW
dc.subject.keywordCryptococcus neoformans,Cryptococcemia,Cryptococcal meningitis,Case-control study,Exact conditional logistic regression,en
dc.relation.page61
dc.rights.note有償授權
dc.date.accepted2014-06-09
dc.contributor.author-college公共衛生學院zh_TW
dc.contributor.author-dept流行病學與預防醫學研究所zh_TW
顯示於系所單位:流行病學與預防醫學研究所

文件中的檔案:
檔案 大小格式 
ntu-103-1.pdf
  未授權公開取用
5.26 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved